Jingwei Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jingwei Li has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Hongqi Zhang
Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China
5 shared publications Chuan He
Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China
4 shared publicationsFan Yang
Department of Neurosurgery, United Family Healthcare, Beijing, China
4 shared publications- Guilin Li
Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China
4 shared publications Feng Ling
Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China
3 shared publicationsJian Ren
Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, China
3 shared publications
Latest Publications
- Open Access
- 27 May 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (4) , 1087-1092
Efficacy and safety of a new mechanical balloon-based flow diverter in the treatment of intracranial aneurysms
Background Flow diverters (FDs) are the first-line treatment of intracranial aneurysms (IAs). A groundbreaking mechanical balloon-based FD device was developed to enhance the precise landing and deployment efficiency for FDs. Objective To investigates the efficacy and safety of this innovative device in a prospective cohort. Methods This study was a prospective multicenter observational study conducted between September 2019 and November 2021. Patients diagnosed with unruptured IAs and treated with this innovative FD device alone were included. The immediate implantation success rate, the successful aneurysm occlusion rate (Raymond I–II or OKM C–D), the complete occlusion rate (Raymond I or OKM D), and the parent artery stenosis rate (>50%) at follow-up were evaluated as the evaluation index of efficacy. The mortality rate, adverse events (AEs), neurological AEs, and serious adverse events (SAEs) were evaluated as the evaluation index of safety. Results A total of 128 patients were included, and all of the FD deployments were successful (success rate reached 100%). At the 12-month mark, 91.4% (117/128) of patients achieved successful occlusion, 85.9% (110/128) achieved complete occlusion, and only 0.8% (1/128) exhibited parent artery stenosis >50% (without need for additional treatment). During the follow-up, there were no reported mortalities or cerebral hemorrhage, while 6 neurological adverse events (4.69%) and 4 SAEs (3.1%) were observed. Conclusions The mechanical balloon-based FD showed a remarkable occlusion rate alongside minimal ischemic and hemorrhagic adverse events compared with existing FDs. This innovative mechanical balloon-based design may be an important direction for future FD design.
- 27 May 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (4) , 1087-1092
Open AccessEfficacy and safety of a new mechanical balloon-based flow diverter in the treatment of intracranial aneurysms
Background Flow diverters (FDs) are the first-line treatment of intracranial aneurysms (IAs). A groundbreaking mechanical balloon-based FD device was developed to enhance the precise landing and deployment efficiency for FDs. Objective To investigates the efficacy and safety of this innovative device in a prospective cohort. Methods This study was a prospective multicenter observational study conducted between September 2019 and November 2021. Patients diagnosed with unruptured IAs and treated with this innovative FD device alone were included. The immediate implantation success rate, the successful aneurysm occlusion rate (Raymond I–II or OKM C–D), the complete occlusion rate (Raymond I or OKM D), and the parent artery stenosis rate (>50%) at follow-up were evaluated as the evaluation index of efficacy. The mortality rate, adverse events (AEs), neurological AEs, and serious adverse events (SAEs) were evaluated as the evaluation index of safety. Results A total of 128 patients were included, and all of the FD deployments were successful (success rate reached 100%). At the 12-month mark, 91.4% (117/128) of patients achieved successful occlusion, 85.9% (110/128) achieved complete occlusion, and only 0.8% (1/128) exhibited parent artery stenosis >50% (without need for additional treatment). During the follow-up, there were no reported mortalities or cerebral hemorrhage, while 6 neurological adverse events (4.69%) and 4 SAEs (3.1%) were observed. Conclusions The mechanical balloon-based FD showed a remarkable occlusion rate alongside minimal ischemic and hemorrhagic adverse events compared with existing FDs. This innovative mechanical balloon-based design may be an important direction for future FD design.
- Open Access
- 10 November 2023
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 9 (4) , 439-445
Surgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations
Background Surgical resection of the lesions remains the main treatment method for most symptomatic spinal cord cavernous malformations (SCCMs) to eliminate the occupation and associated subsequent lifelong haemorrhagic risk. However, the timing of surgical intervention remains controversial, especially for patients in the acute stage after severe haemorrhage. Methods Patients diagnosed with SCCMs who were surgically treated between January 2002 and December 2021 were selected and retrospectively reviewed. The Modified McCormick Scale (MMS) was used to evaluate neurological and disability status. All medical information was reviewed, and all patients were followed up for at least 6 months. Results A total of 279 patients were ultimately included. With regard to long-term outcomes, 110 (39.4%) patients improved, 159 (57.0%) remained unchanged and 10 (3.6%) worsened. For patients with an MMS score of 2–5 on admission, in univariate and multivariate analyses, a ≤6 weeks period between onset and surgery (adjusted OR 3.211, 95% CI 1.504 to 6.856, p=0.003) was a significant predictor of improved MMS. Among 69 patients who first presented with severe haemorrhage, undergoing surgery within 6 weeks of the onset of severe haemorrhage (adjusted OR 4.901, 95% CI 1.126 to 21.325, p=0.034) was significantly associated with improvement of MMS score. Conclusion Surgical timing can influence the long-term outcome of SCCMs. For patients with symptomatic SCCMs, especially those with severe haemorrhage, early surgical intervention within 6 weeks can provide more benefit.
- 10 November 2023
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 9 (4) , 439-445
Open AccessSurgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations
Background Surgical resection of the lesions remains the main treatment method for most symptomatic spinal cord cavernous malformations (SCCMs) to eliminate the occupation and associated subsequent lifelong haemorrhagic risk. However, the timing of surgical intervention remains controversial, especially for patients in the acute stage after severe haemorrhage. Methods Patients diagnosed with SCCMs who were surgically treated between January 2002 and December 2021 were selected and retrospectively reviewed. The Modified McCormick Scale (MMS) was used to evaluate neurological and disability status. All medical information was reviewed, and all patients were followed up for at least 6 months. Results A total of 279 patients were ultimately included. With regard to long-term outcomes, 110 (39.4%) patients improved, 159 (57.0%) remained unchanged and 10 (3.6%) worsened. For patients with an MMS score of 2–5 on admission, in univariate and multivariate analyses, a ≤6 weeks period between onset and surgery (adjusted OR 3.211, 95% CI 1.504 to 6.856, p=0.003) was a significant predictor of improved MMS. Among 69 patients who first presented with severe haemorrhage, undergoing surgery within 6 weeks of the onset of severe haemorrhage (adjusted OR 4.901, 95% CI 1.126 to 21.325, p=0.034) was significantly associated with improvement of MMS score. Conclusion Surgical timing can influence the long-term outcome of SCCMs. For patients with symptomatic SCCMs, especially those with severe haemorrhage, early surgical intervention within 6 weeks can provide more benefit.
- 1 October 2023
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (10) , E440-E441
Hematomyelia Caused by an Intraparenchymal Varix Rupture of a Spinal Dural Arteriovenous Fistula
- 1 October 2023
- Published by Wolters Kluwer Health in Stroke
- Vol. 54 (10) , E440-E441
Hematomyelia Caused by an Intraparenchymal Varix Rupture of a Spinal Dural Arteriovenous Fistula
- Open Access
A proposed grading system for spinal cord arteriovenous shunts
Background: The clinical outcomes of microsurgery for spinal cord arteriovenous shunts (SCAVSs) exhibit fluctuations due to varying patient selection criteria, underscoring the importance of a standardized surgical grading system that can effectively stratify the feasibility of SCAVSs resection. Methods: A cohort of 308 consecutive patients with surgically treated SCAVSs was randomly divided into a modeling group and a validation group. The surgical grading system was developed based on the independent risk factors of incomplete resection identified in the modeling group and subsequently verified in the validation group. The system’s specificity and sensitivity were tested through Receiver Operating Characteristic (ROC) analyses. Results: Multivariate analysis indicated that metameric AVSs (p=0.007), AVSs with maximum length ≥3 cm (p=0.017), embedded AVSs (p=0.032) and anterior sulcal artery supply (p=0.013) were independent risk factors of incomplete resection. Subsequently, each of the four parameters is assigned one point, and the SCAVSs grade is calculated by aggregating all parameter scores. The area under ROC curve (AUC) of modeling group and validation group was 0.856 (95% confidence interval [95% CI], 0.794-0.919) and 0.819 (95% CI, 0.747-0.892) respectively. Across the entire cohort, patients with scores ranging from 0 to 4 exhibited complete resection rates of 88.7%, 66.7%, 30.6%, 4.5% and 6.3%. The corresponding rates of severe treatment-related deterioration were found to be at levels of 6.0%, 12.0%, 12.9%, 31.8% and 25.0 %, respectively. Conclusion: The proposed grading system effectively stratifies the surgical feasibility of SCAVSs based on both the probability of achieving complete resection and the treatment risk. Its simplicity renders it a valuable tool for clinical decision-making, as well as a reference point for evaluating treatment outcomes across different centers and surgical techniques.
Open AccessA proposed grading system for spinal cord arteriovenous shunts
Background: The clinical outcomes of microsurgery for spinal cord arteriovenous shunts (SCAVSs) exhibit fluctuations due to varying patient selection criteria, underscoring the importance of a standardized surgical grading system that can effectively stratify the feasibility of SCAVSs resection. Methods: A cohort of 308 consecutive patients with surgically treated SCAVSs was randomly divided into a modeling group and a validation group. The surgical grading system was developed based on the independent risk factors of incomplete resection identified in the modeling group and subsequently verified in the validation group. The system’s specificity and sensitivity were tested through Receiver Operating Characteristic (ROC) analyses. Results: Multivariate analysis indicated that metameric AVSs (p=0.007), AVSs with maximum length ≥3 cm (p=0.017), embedded AVSs (p=0.032) and anterior sulcal artery supply (p=0.013) were independent risk factors of incomplete resection. Subsequently, each of the four parameters is assigned one point, and the SCAVSs grade is calculated by aggregating all parameter scores. The area under ROC curve (AUC) of modeling group and validation group was 0.856 (95% confidence interval [95% CI], 0.794-0.919) and 0.819 (95% CI, 0.747-0.892) respectively. Across the entire cohort, patients with scores ranging from 0 to 4 exhibited complete resection rates of 88.7%, 66.7%, 30.6%, 4.5% and 6.3%. The corresponding rates of severe treatment-related deterioration were found to be at levels of 6.0%, 12.0%, 12.9%, 31.8% and 25.0 %, respectively. Conclusion: The proposed grading system effectively stratifies the surgical feasibility of SCAVSs based on both the probability of achieving complete resection and the treatment risk. Its simplicity renders it a valuable tool for clinical decision-making, as well as a reference point for evaluating treatment outcomes across different centers and surgical techniques.
- Open Access
- 6 January 2023
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 8 (4) , 292-300
Angioarchitecture and prognosis of pediatric intracranial pial arteriovenous fistula
Objective Pial arteriovenous fistulas (PAVFs) are rare and mostly observed in children. However, the overall angioarchitecture, clinical features, treatments and long-term prognosis for pediatric patients remain unclear. Methods Clinical data of consecutive 42 pediatric PAVFs were documented and analysed. According to the differences of age distribution and clinical features, they were split into a younger group (≤3 years old; 20 cases) and an older group (3–14 years old; 22 cases). Results Their mean age was 4.9±3.9 years, and the mean preoperative modified Rankin Scale (mRS) score was 1.64±1.57. Fourteen patients (33.3%) were asymptomatic, followed by epilepsy (21.4%), intracranial haemorrhage (16.7%), hydrocephalus (9.5%), developmental delay (7.1%), intermittent headache (7.1%) and congestive heart failure (4.8%). Annual bleeding rate and rebleeding rate before treatment reached 3.86% and 3.17%. Poor venous drainage including sinus dynamic obstruction (21 cases, 50.0%) and sinus occlusion (17 cases, 40.48%) were found with high frequency among these patients. Finally, 33 cases were cured (78.57%), and 4 cases faced surgery-related complications (9.52%). During 24–140 months’ follow-up, the mean mRS score reduced to 0.57±0.40. However, only 22 cases (52.38%) recovered to absolutely normal, and poor venous drainage was the risk factor for patients’ incomplete recovery (p=0.028, Exp(B)=14.692, 95% CI 1.346 to 160.392). Compared with the older group, younger group showed more chronic symptoms, more secondary pathological changes, more times treatment and worse prognosis (p=0.013, 0.002, 0.000 and 0.032, respectively). Conclusions Pediatric PAVF has different angioarchitectures, clinical features and prognoses in different age groups. Poor venous drainage is an important factor leading to poor prognosis, and it accounts for incomplete recovery in nearly half of patients.
- 6 January 2023
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 8 (4) , 292-300
Open AccessAngioarchitecture and prognosis of pediatric intracranial pial arteriovenous fistula
Objective Pial arteriovenous fistulas (PAVFs) are rare and mostly observed in children. However, the overall angioarchitecture, clinical features, treatments and long-term prognosis for pediatric patients remain unclear. Methods Clinical data of consecutive 42 pediatric PAVFs were documented and analysed. According to the differences of age distribution and clinical features, they were split into a younger group (≤3 years old; 20 cases) and an older group (3–14 years old; 22 cases). Results Their mean age was 4.9±3.9 years, and the mean preoperative modified Rankin Scale (mRS) score was 1.64±1.57. Fourteen patients (33.3%) were asymptomatic, followed by epilepsy (21.4%), intracranial haemorrhage (16.7%), hydrocephalus (9.5%), developmental delay (7.1%), intermittent headache (7.1%) and congestive heart failure (4.8%). Annual bleeding rate and rebleeding rate before treatment reached 3.86% and 3.17%. Poor venous drainage including sinus dynamic obstruction (21 cases, 50.0%) and sinus occlusion (17 cases, 40.48%) were found with high frequency among these patients. Finally, 33 cases were cured (78.57%), and 4 cases faced surgery-related complications (9.52%). During 24–140 months’ follow-up, the mean mRS score reduced to 0.57±0.40. However, only 22 cases (52.38%) recovered to absolutely normal, and poor venous drainage was the risk factor for patients’ incomplete recovery (p=0.028, Exp(B)=14.692, 95% CI 1.346 to 160.392). Compared with the older group, younger group showed more chronic symptoms, more secondary pathological changes, more times treatment and worse prognosis (p=0.013, 0.002, 0.000 and 0.032, respectively). Conclusions Pediatric PAVF has different angioarchitectures, clinical features and prognoses in different age groups. Poor venous drainage is an important factor leading to poor prognosis, and it accounts for incomplete recovery in nearly half of patients.
- 13 February 2022
- Published by Wiley in Annals of Neurology
- Vol. 91 (4) , 575-577
Inherited Pial Arteriovenous Fistula in Capillary Malformation–Arteriovenous Malformation Family
- 13 February 2022
- Published by Wiley in Annals of Neurology
- Vol. 91 (4) , 575-577
Inherited Pial Arteriovenous Fistula in Capillary Malformation–Arteriovenous Malformation Family
- 27 September 2018
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 11 (4) , 411-415
Pediatric perimedullary arteriovenous fistula: clinical features and endovascular treatments
Objective Pediatric spinal perimedullary arteriovenous fistula (PMAVF) is rare but may cause permanent disability. We aim to summarize the clinical features of pediatric PMAVFs and our clinical experience in their treatment and to evaluate the effect of endovascular treatment in a large cohort. Methods From 2008 to 2017, 51 PMAVFs in pediatric patients (Results Thirty-eight boys and thirteen girls were included, and the mean age at presentation was 5.6±4.1 years. Acute neurological deterioration was identified in 33 patients, and 21 of those patients (63.6%) suffered from bleeding. The annual bleeding rate before treatment was 2.55%. After transarterial embolization with coils and glue, 46 PMAVFs (90.2%) were completely occluded, and five (9.8%) were obliterated by supplementary microsurgery. During a follow-up period of 6 to 119 months (mean 58.4±16.7 months), the patients’ clinical states were improved in 42 cases (82.4%), stationary in nine cases (17.6%), and aggravated in none. Type IVc patients had a longer preoperative period, more chronic symptoms, a lower cure rate by embolization, and less improvement of symptoms than type IVb patients had (PConclusions Pediatric PMAVF is a special subgroup of intradural arteriovenous shunt that should be treated early. Endovascular embolization is safe and effective in the treatment of pediatric PMAVFs.
- 27 September 2018
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 11 (4) , 411-415
Pediatric perimedullary arteriovenous fistula: clinical features and endovascular treatments
Objective Pediatric spinal perimedullary arteriovenous fistula (PMAVF) is rare but may cause permanent disability. We aim to summarize the clinical features of pediatric PMAVFs and our clinical experience in their treatment and to evaluate the effect of endovascular treatment in a large cohort. Methods From 2008 to 2017, 51 PMAVFs in pediatric patients (Results Thirty-eight boys and thirteen girls were included, and the mean age at presentation was 5.6±4.1 years. Acute neurological deterioration was identified in 33 patients, and 21 of those patients (63.6%) suffered from bleeding. The annual bleeding rate before treatment was 2.55%. After transarterial embolization with coils and glue, 46 PMAVFs (90.2%) were completely occluded, and five (9.8%) were obliterated by supplementary microsurgery. During a follow-up period of 6 to 119 months (mean 58.4±16.7 months), the patients’ clinical states were improved in 42 cases (82.4%), stationary in nine cases (17.6%), and aggravated in none. Type IVc patients had a longer preoperative period, more chronic symptoms, a lower cure rate by embolization, and less improvement of symptoms than type IVb patients had (PConclusions Pediatric PMAVF is a special subgroup of intradural arteriovenous shunt that should be treated early. Endovascular embolization is safe and effective in the treatment of pediatric PMAVFs.